Biomarin Pharmaceutical (BMRN) Shares Issued: 2009-2025
Historic Shares Issued for Biomarin Pharmaceutical (BMRN) over the last 13 years, with Sep 2025 value amounting to $7,000.
- Biomarin Pharmaceutical's Shares Issued fell 99.85% to $7,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year decrease of 63.76%. This contributed to the annual value of $49.3 million for FY2024, which is 28.95% down from last year.
- Per Biomarin Pharmaceutical's latest filing, its Shares Issued stood at $7,000 for Q3 2025, which was down 99.91% from $7.7 million recorded in Q2 2025.
- Biomarin Pharmaceutical's 5-year Shares Issued high stood at $29.4 million for Q2 2024, and its period low was $7,000 during Q3 2025.
- Its 3-year average for Shares Issued is $12.6 million, with a median of $7.8 million in 2024.
- In the last 5 years, Biomarin Pharmaceutical's Shares Issued skyrocketed by 174.45% in 2022 and then plummeted by 99.85% in 2025.
- Quarterly analysis of 5 years shows Biomarin Pharmaceutical's Shares Issued stood at $16.3 million in 2021, then skyrocketed by 56.08% to $25.5 million in 2022, then slumped by 41.87% to $14.8 million in 2023, then crashed by 46.90% to $7.9 million in 2024, then plummeted by 99.85% to $7,000 in 2025.
- Its last three reported values are $7,000 in Q3 2025, $7.7 million for Q2 2025, and $7.9 million during Q4 2024.